NEW YORK, Oct. 7-IDEC Pharmaceuticals has extended its subscription to Gene Logic's oncology database, Gene Logic said today.
IDEC initially subscribed to the company's Oncology DataSuite, which includes microarray-derived gene expression profiles from a variety of human cancers, in January 2000. The company will use this information to develop cancer therapies.
The company did not reveal financial terms of the deal